Premium
Diacylglycerol treatment rapidly decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells
Author(s) -
SinnettSmith James W.,
Rozengurt Enrique
Publication year - 1985
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1041240114
Subject(s) - diacylglycerol kinase , protein kinase c , epidermal growth factor , receptor , phorbol , 3t3 cells , ligand (biochemistry) , protein kinase a , chemistry , biology , biochemistry , endocrinology , medicine , kinase , transfection , gene
The synthetic diacylglycerol 1‐oleoyl‐2‐acetyl glycerol (OAG) and phorbol esters activate protein kinase C in intact cells. We report here that OAG inhibits the binding of 125 I‐labelled epidermal growth factor ( 125 I‐EGF) to Swiss 3T3 cells. The inhibition was detected as early as 1 min after treatment at 37°C and persisted for at least 120 min. The effect of OAG was reversed upon removal of this diacylglycerol. Detailed Scatchard analysis of 125 I‐EGF binding to Swiss 3T3 cells at 4°C after a 1 h incubation with a saturating dose of OAG at 37°C, demonstrates that this OAG pretreatment does not change the apparent number of EGF receptors but causes a marked decrease in their apparent affinity for the ligand. Prolonged treatment (40 h) of the cells with phorbol dibutyrate (PBt 2 ) which causes a marked decrease in the number of phorbol ester binding sites and in the activity of protein kinase C, prevented the inhibition of 125 I‐EGF binding by both PBt 2 and OAG. The results support the possibility that protein kinase C plays a role in the transmodulation of the EGF receptor in intact cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom